Cargando…

Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside

This review summarizes the main achievements in basic and clinical research of atherosclerosis. Focusing on desialylation as the first and the most important reaction of proatherogenic pathological cascade, we speak of how desialylation increases the atherogenic properties of low density lipoprotein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mezentsev, Alexandre, Bezsonov, Evgeny, Kashirskikh, Dmitry, Baig, Mirza S., Eid, Ali H., Orekhov, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228531/ https://www.ncbi.nlm.nih.gov/pubmed/34070542 http://dx.doi.org/10.3390/biomedicines9060600

Ejemplares similares

Thirty-Five-Year History of Desialylated Lipoproteins Discovered by Vladimir Tertov
por: Glanz, Victor, et al.
Publicado: (2022)

Sialidase Activity in Human Blood Serum Has a Distinct Seasonal Pattern: A Pilot Study
por: Glanz, Victor Y., et al.
Publicado: (2020)

Lipids and Lipoproteins in Health and Disease
por: Bezsonov, Evgeny E., et al.
Publicado: (2021)

Lipids and Lipoproteins in Atherosclerosis
por: Bezsonov, Evgeny, et al.
Publicado: (2023)

The Interaction of Plasma Sialylated and Desialylated Lipoproteins with Collagen from the Intima and Media of Uninvolved and Atherosclerotic Human Aorta
por: Sobenin, Igor A., et al.
Publicado: (2011)

Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low‐Density Lipoproteins and Increasing Their Uptake by Macrophages
por: Demina, Ekaterina P., et al.
Publicado: (2021)

High-density lipoproteins during sepsis: from bench to bedside
por: Tanaka, Sébastien, et al.
Publicado: (2020)

Desialylation of Atg5 by sialidase (Neu2) enhances autophagosome formation to induce anchorage-dependent cell death in ovarian cancer cells
por: Satyavarapu, Eswara Murali, et al.
Publicado: (2021)

Functional and structural analyses reveal that a dual domain sialidase protects bacteria from complement killing through desialylation of complement factors
por: Clark, Nicholas D., et al.
Publicado: (2023)

Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Mitochondrial Lipid Homeostasis at the Crossroads of Liver and Heart Diseases
por: Dabravolski, Siarhei A., et al.
Publicado: (2021)

Bench and Bedside
por: Schmidt, Christian
Publicado: (2002)

Lipoprotein Subfraction Cholesterol Distribution Is Proatherogenic in Women With Type 1 Diabetes and Insulin Resistance
por: Maahs, David M., et al.
Publicado: (2010)

Desialylation of platelet surface glycans enhances platelet adhesion to adsorbent polymers for lipoprotein apheresis
por: Lauková, Lucia, et al.
Publicado: (2020)

From bench to bedside
por: Verdant, Colin L
Publicado: (2012)

Oxidized-Desialylated Low-Density Lipoprotein Inhibits the Antitumor Functions of Lymphokine Activated Killer Cells
por: Aguilar Díaz de león, Jesús S, et al.
Publicado: (2021)

Sex Differences in Proatherogenic Cytokine Levels
por: Bernardi, Stella, et al.
Publicado: (2020)

Proatherogenic Oxidized Low-Density Lipoprotein/β2-Glycoprotein I Complexes in Arterial and Venous Disease
por: Berger, Jeffrey S., et al.
Publicado: (2014)

Proteoglycan binding as proatherogenic function metric of apoB-containing lipoproteins and chronic kidney graft failure
por: Steffen, Hannah L.M., et al.
Publicado: (2021)

Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics
por: Rytkin, Eric, et al.
Publicado: (2023)

Editorial: Lipids and inflammation in health and disease, volume II
por: Bezsonov, Evgeny, et al.
Publicado: (2023)

Inhibition of sialidase activity as a therapeutic approach
por: Glanz, Victor Yu, et al.
Publicado: (2018)

Sepsis: From Bench to Bedside
por: Silva, Eliézer, et al.
Publicado: (2008)

Sonochemotherapy: from bench to bedside
por: Lammertink, Bart H. A., et al.
Publicado: (2015)

Nutrition: From Bench to Bedside
por: Khan, Naim A., et al.
Publicado: (2016)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Pruritus: From the Bench to the Bedside
por: Reich, Adam, et al.
Publicado: (2018)

Silver linings at the bench and bedside
por: Katz, Steven C., et al.
Publicado: (2020)

Olutasidenib: from bench to bedside
por: Venugopal, Sangeetha, et al.
Publicado: (2023)

Bench-To-Bedside and Bedside Back to the Bench; Coordinating Clinical and Experimental Traumatic Brain Injury Studies
por: Agoston, Denes V., et al.
Publicado: (2012)

Oxidized Phospholipids are Proinflammatory and Proatherogenic in Hypercholesterolemic Mice
por: Que, Xuchu, et al.
Publicado: (2018)

Current Knowledge in Thyroid Cancer—From Bench to Bedside
por: Grimm, Daniela
Publicado: (2017)

Current Medical Therapy for Adenomyosis: From Bench to Bedside
por: Etrusco, Andrea, et al.
Publicado: (2023)

Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk
por: Dabravolski, Siarhei A., et al.
Publicado: (2021)

The Role of Mitochondrial Mutations and Chronic Inflammation in Diabetes
por: Dabravolski, Siarhei A., et al.
Publicado: (2021)

The expanding roles of neuronal nitric oxide synthase (NOS1)
por: Solanki, Kundan, et al.
Publicado: (2022)

Investigating population-level immunosenescence: From bench to bedside
por: Cunha, Lucas Leite, et al.
Publicado: (2022)

Bench-to-bedside review: An approach to hemodynamic monitoring - Guyton at the bedside
por: Magder, Sheldon
Publicado: (2012)

Research in Sickle Cell Disease: From Bedside to Bench to Bedside
por: Salinas Cisneros, Gabriel, et al.
Publicado: (2021)

Cancer proteomics: from bench to bedside
por: Timms, J F
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_c1km6q05n0l4q7d713udni27d5